NCT05300373View on ClinicalTrials.gov

Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

January 3, 2022

Study Completion Date

December 3, 2023

Conditions
Adenosine Deaminase Deficiency
Interventions
DIAGNOSTIC_TEST

ADENOSINE DEAMINASE TEST

ADENOSINE DEAMINASE DEFICIENCY TEST

Trial Locations (1)

Unknown

Konya Necmettin Erbakan University, Konya

Sponsors

Lead Sponsor

TRPHARM
All Listed Sponsors
lead

TRPHARM

INDUSTRY

NCT05300373 - Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E | Biotech Hunter | Biotech Hunter